R&D Systems™ Recombinant Human VEGF-111b Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human VEGF-111b Protein is derived from E. coli. The Recombinant Human VEGF-111b Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: P15692-1
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 7422
• Molecular Weight (g/mol): 13 kDa
• Quantity: 50 μg
• Source: E. coli-derived human VEGF protein Ala27-Arg131,followed by SLTRKD (B isoform,Reference 7)
• Storage Requirements: 12 months from date of receipt, <= -20 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU per 1 μg of the protein by the LAL method.
• Specific Reactivity: VEGF
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 500 μg/mL in 4 mM HCl.
• Buffer: Lyophilized from a 0.2 μm filtered solution in HCl.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.